Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Valeant Pharmaceuticals Intl Inc (VRX.TO)

Valeant Pharmaceuticals Intl Inc (VRX.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,758,416
  • Shares Outstanding, K 349,299
  • Annual Sales, $ 8,724 M
  • Annual Income, $ 2,404 M
  • 60-Month Beta -1.49
  • Price/Sales 0.96
  • Price/Cash Flow N/A
  • Price/Book 1.85
Trade VRX.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -2.64
  • Most Recent Earnings -7.68 on 03/31/18
  • Next Earnings Date 08/14/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 1.000 on 11/10/10
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate 1.04
  • Number of Estimates 6
  • High Estimate 1.19
  • Low Estimate 0.91
  • Prior Year 1.41
  • Growth Rate Est. (year over year) -26.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.80 +3.36%
on 07/06/18
35.73 -13.80%
on 06/15/18
-4.09 (-11.72%)
since 06/13/18
3-Month
21.10 +45.97%
on 04/16/18
36.02 -14.49%
on 06/13/18
+9.18 (+42.46%)
since 04/13/18
52-Week
14.01 +119.84%
on 11/02/17
36.02 -14.49%
on 06/13/18
+8.78 (+39.87%)
since 07/13/17

Most Recent Stories

More News
Active Electronic Components Market : 2021-2030 Projection Comprehensive Research and Predictive Business Strategies | Infineon Technologies AG, NXP Semiconductors NV

A consciously conceived and designed business intelligence report titled Global  by Manufacturers, Type, and Application, Forecast to 2030 by discloses a succinct analysis of the regional spectrum,...

ADI : 150.81 (-2.26%)
IFNNY : 40.8700 (-3.13%)
INTC : 60.16 (-1.76%)
IBM : 122.39 (+1.71%)
QCOM : 131.97 (-3.70%)
TKPYY : 16.5900 (-0.90%)
TOSBF : 31.9900 (+2.11%)
VRX.TO : 30.80 (-3.33%)
Global Conjunctivitis Drugs Market Price Trends 2020, Industry, Analysis, Report and Forecast To 2027

Japan, Japan, Tue, 02 Mar 2021 01:59:47 / Comserve Inc. / -- Key Players: The major players in the market include Novartis, Valeant Pharmaceuticals International, Teva Pharmaceuticals, and Akron Inc. Perrigo...

BAYRY : 15.5435 (-1.75%)
MRK : 73.50 (+0.89%)
NVS : 87.67 (-0.57%)
VRX.TO : 30.80 (-3.33%)
Antifungal Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The Global is poised to value over USD 19.7 billion by 2027 end at a CAGR of over 3.7% during the forecast period 2020 to 2027.

ABT : 119.45 (-2.51%)
ALPMF : 15.7110 (-0.44%)
BAYRY : 15.5435 (-1.75%)
ENZN : 0.4800 (-6.92%)
GILD : 62.86 (-0.24%)
GSK : 34.30 (+0.62%)
MRK : 73.50 (+0.89%)
NVS : 87.67 (-0.57%)
VRX.TO : 30.80 (-3.33%)
Adult Vaccines Market Industry To Reach A New Threshold of Growth By 2030 | Merck & Co. Inc, Emergent BioSolutions Inc

A consciously conceived and designed business intelligence report titled Global  by Manufacturers, Type, and Application, Forecast to 2030 by discloses a succinct analysis of the regional spectrum,...

ABT : 119.45 (-2.51%)
ACXIF : 157.7500 (-2.06%)
AZN : 47.23 (-1.05%)
BASFY : 21.3740 (+0.82%)
CSLLY : 103.2500 (-2.71%)
GSK : 34.30 (+0.62%)
MRK : 73.50 (+0.89%)
NVS : 87.67 (-0.57%)
PFE : 34.42 (+2.72%)
SIEGY : 80.0300 (+2.14%)
VRX.TO : 30.80 (-3.33%)
Varicella Zoster Infection Treatment Market to 2027, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027 | Valeant Pharmaceuticals International Inc., Teva Pharmaceutical Industries Ltd, Pfizer Inc. | FMI Report

Future Market Insights (FMI) has published a new report on the titled "Varicella Zoster Infection Treatment Market: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027." Varicella...

ABT : 119.45 (-2.51%)
GSK : 34.30 (+0.62%)
NVS : 87.67 (-0.57%)
PFE : 34.42 (+2.72%)
TEVA : 10.92 (+1.77%)
VRX.TO : 30.80 (-3.33%)
Global Premium Intraocular Lens Professional Survey Report 2021, Forecast to 2026

Premium IOLs provide a better range of vision after cataract surgery or refractive lens exchange. Because these lenses can treat cataracts while improving distance, intermediate, and near vision, most...

CZMWF : 150.0000 (-2.79%)
NVS : 87.67 (-0.57%)
VRX.TO : 30.80 (-3.33%)
Global Cancer Pain Management Solutions Market 2020 with Impact of COVID-19 Outbreak, SWOT Study, Steady Growth and Forecast 2025

The latest intelligence report titled explains significant details asked by the customers in terms of industrial advantages or disadvantages and futuristic industry scope. The report offers investigations...

ENDP : 6.90 (-4.56%)
GSK : 34.30 (+0.62%)
TEVA : 10.92 (+1.77%)
VRX.TO : 30.80 (-3.33%)
Norovirus Infection Treatment Market Manufacture Size, Developments And Future Scope To 2031

A recent systematic review report on came out Market.us research added in various regions to produce more than 200+ page reports. The research also emphasizes the impact of restraints, drivers, and macro...

VRX.TO : 30.80 (-3.33%)
Current research: Ophthalmic Devices Market key players insight & growth driver analysis 2021

The global ophthalmic devices market was valued at $53,428.8 million in 2019, and is projected to reach $66,719.3 million by 2027, registering a CAGR of 4.2% from 2020 to 2027.

CZMWF : 150.0000 (-2.79%)
NVS : 87.67 (-0.57%)
STAA : 95.34 (-8.11%)
VRX.TO : 30.80 (-3.33%)
Intravitreal (IVT) Injectables Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The Global is poised to register a CAGR of over 4.7% during the forecast period 2020 to 2027.

ALIM : 8.20 (-8.89%)
AGN : 193.02 (+0.02%)
NVS : 87.67 (-0.57%)
REGN : 447.38 (-1.64%)
VRX.TO : 30.80 (-3.33%)

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 32.69
1st Resistance Point 31.74
Last Price 30.80
1st Support Level 30.30
2nd Support Level 29.81
3rd Support Level N/A

See More

52-Week High 36.02
Last Price 30.80
Fibonacci 61.8% 27.61
Fibonacci 50% 25.01
Fibonacci 38.2% 22.42
52-Week Low 14.01

See More

Business Summary

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar